Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $49.48 USD
Change Today -1.08 / -2.14%
Volume 2.2M
DD On Other Exchanges
New York
EN Paris
As of 11:28 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Sven Thormahlen Ph.D.

AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 5 different industries.

See Board Relationships


Dr. Sven Thormahlen, Ph.D. has been Chief Technology Officer and Member of Management Board at Corbion N.V. since May 12, 2014. Dr. Thormahlen serves as Chief Executive Officer of MucoVax. He served as an Executive Vice President of Danone Research and General Manager of Research & Development at Groupe Danone. Dr. Thormahlen served as the International Executive Director of Research and Development at Groupe Danone in France until May 2011. In this role, Dr. Thormahlen ...

Read Full Background

Corporate Headquarters*

974 Centre Road
Wilmington, Delaware 19805

United States

Phone: 302-774-1000
Fax: --

Board Members Memberships*



Universität Hamburg

Other Affiliations*

Annual Compensation*

Total Annual Compensation€408,000

Stock Options*

All Other Compensation€116,000

Total Compensation*

Total Annual Cash Compensation€524,000
Total Short Term Compensation€408,000
Other Long Term Compensation€116,000
Total Calculated Compensation€524,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DD:US $49.48 USD -1.08


Theodore L. Harris Chief Executive Officer, President and Director
Balchem Corp.
Paul Manning Chief Executive Officer, President, Director, Member of Executive Committee, Member of Finance Committee and Member of Scientific Advisory Committee
Sensient Technologies Corporation
Christophe P. J. Barnouin Chief Executive Officer and Member of Executive Board
Koninklijke Wessanen N.V.
Joseph H. Shaulson Chief Executive Officer, President and Director
Metabolix, Inc.
Jonathan S. Wolfson Co-Founder, Chief Executive Officer and Director
Solazyme, Inc.
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DU PONT (E.I.) DE NEMOURS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at